Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1993
11/11/1993WO1993021963A2 Carboxamide modified polyamine chelators and radioactive complexes and conjugation
11/11/1993WO1993021959A1 Bystander effect tumoricidal therapy
11/11/1993WO1993021956A1 Antibodies to p-selectin and their uses
11/11/1993WO1993021951A1 Method for producing a bacterial vaccine and novel vaccines produced thereby
11/11/1993WO1993021950A1 Vaccine compositions for mucosal delivery
11/11/1993WO1993021948A1 Peptide-carbohydrate conjugates generating t-cell immunity
11/11/1993WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993WO1993021769A1 Diphtheria toxin receptor-binding region
11/11/1993WO1993020103A3 Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification
11/11/1993WO1993018163A3 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
11/11/1993WO1993017712A3 Conjugates formed from heat shock proteins and oligo- or polysaccharides
11/11/1993CA2135052A1 Diphtheria toxin receptor-binding region
11/11/1993CA2134763A1 Bystander effect tumoricidal therapy
11/11/1993CA2134678A1 Fanconi anemia gene for complementation group c
11/11/1993CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals
11/11/1993CA2134666A1 Cdna sequence of dengue virus serotype 1 (singapore strain)
11/11/1993CA2134655A1 Modulation of thrombospondin-cd36 interactions
11/11/1993CA2134550A1 Human crabp-i and crabp-ii
11/11/1993CA2134443A1 Inhibitory factor
11/11/1993CA2134097A1 Peptide-carbohydrate conjugates generating t-cell immunity
11/11/1993CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993CA2112798A1 Peptides of human papilloma virus for use in human t cell response inducing compositions
11/10/1993EP0569309A1 Hepatitis C virus synthetic polypeptides usable for detection of the virus
11/10/1993EP0568925A2 TNF receptor action modulation
11/10/1993EP0568726A2 Stabilized varicella live vaccine
11/10/1993EP0568645A1 Mixed specificity fusion proteins
11/10/1993EP0568631A1 Monoclonal antibodies to elam-1 and their uses
11/10/1993EP0568623A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/10/1993EP0568622A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp)
11/10/1993EP0568539A1 Soluble mannose receptor peptides
11/10/1993CN1078153A Methods for using histamine derivatives as immunomodulators and in immunotherapeutics
11/09/1993US5260429 Purified DNA of the 170-kd surface Gal/GalNAc adherence lectin of pathogenic E. histolytica
11/09/1993US5260422 MHC conjugates useful in ameliorating autoimmunity
11/09/1993US5260416 Antigenic epitopes present on membrane-bound but not secreted IgE
11/09/1993US5260373 Immobilized immunoglobulin-binding proteins
11/09/1993US5260271 Combined with a chelating agent
11/09/1993US5260223 Methods for detection of human gamma, γ T cell receptor
11/09/1993US5260210 Blood-brain barrier model
11/09/1993US5260209 Useful for immunization to produce antibodies; diagnosis of genetic defect which causes muscular dystrophy
11/09/1993US5260057 Method and product for the treatment of gastric disease
11/09/1993CA1324100C Multiple stage affinity process for isolation of specific cells from a cell mixture
11/09/1993CA1324094C Hepatitis a virus vaccines
11/09/1993CA1324079C Enhanced uptake drug delivery system
11/09/1993CA1324076C Swine dysentery vaccine
11/09/1993CA1324075C Bordetella bronchiseptica vaccine
11/08/1993CA2095588A1 Synthetic lipid a glycoconjugate antigens for use in vaccines
11/07/1993CA2095693A1 Synthetic polypeptides of the hepatitis c virus (hcv), which may be used to detect the said virus
11/03/1993EP0568178A1 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
11/03/1993EP0567585A1 HEPATIC GROWTH FACTOR RECEPTOR IS THE $i(MET) PROTO-ONCOGENE
11/03/1993EP0567577A1 Nucleotidic sequences coding for the murine adrenergic beta 3 receiver and applications thereof
11/03/1993EP0567514A1 A METHOD AND A SYSTEM FOR ENHANCED $i(IN VIVO) CLEARANCE OF DIAGNOSTIC AND/OR THERAPEUTIC AGENTS BY EXTRACORPOREAL DEPLETION, AND THE USE OF SAID AGENTS FOR SAID PURPOSE
11/03/1993EP0567512A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine
11/03/1993EP0567503A1 Pasteurella haemolytica glycoprotease gene
11/03/1993EP0567470A1 Pseudomonas peptide composition and method for producing the same
11/03/1993EP0567450A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
11/03/1993EP0374182B1 Biospecific polymers
11/03/1993EP0316320B1 Reduction of reproductive losses
11/03/1993CN1077991A Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
11/02/1993US5258504 Process for the purification of streptolysin O, intact streptolysin O obtainable by this process
11/02/1993US5258381 Inhibitors of glycosylation of proteins, antiaging agents, discoloration inhibition of teeth and storage stability of foods
11/02/1993US5258294 Plasmid cloning vector with genomic library from DNA and virus isolation and insertion a promoter element
11/02/1993US5258287 DNA sequences and hybrids
11/02/1993US5258178 Antibodies from cows milk which prevent gastritis
11/02/1993US5258177 Immunoglobulins, plasminogens in water solution by adding caprylate salts
10/1993
10/30/1993WO1993022682A1 In vitro test for helicobacter pylori
10/28/1993WO1993021532A1 METHOD FOR THE DETERMINATION OF PLASMIN/α2-ANTIPLASMIN COMPLEXES AND THE USE OF THIS METHOD AS A MEAN OF DETERMINING CHANGES IN THE FIBRINOLYTIC SYSTEM
10/28/1993WO1993021332A1 Hybrid particles
10/28/1993WO1993021331A2 Polysaccharide binding fusion proteins and conjugates
10/28/1993WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993WO1993021325A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993WO1993021324A1 Recombinant mutants for inducing specific immune responses
10/28/1993WO1993021323A1 Haemophilus somnus immunogenic proteins
10/28/1993WO1993021321A2 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021317A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
10/28/1993WO1993021316A1 Mammalian melanocyte stimulating hormone receptors and uses
10/28/1993WO1993021314A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993WO1993021310A1 Attenuated respiratory syncytial virus vaccine compositions
10/28/1993WO1993021306A1 Genetically engineered attenuated viruses
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021232A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS
10/28/1993WO1993021223A1 Methods and reagents for diagnosis of autoantibodies
10/28/1993WO1993021222A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
10/28/1993WO1993021220A1 Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection
10/28/1993WO1993021218A1 Synthetic polypeptides derived from the hiv envelope glycoprotein
10/28/1993WO1993021206A1 Synthetic, stabilized, three-dimension polypeptides
10/28/1993WO1993021151A1 Substituted thioureas as bifunctional chelators
10/28/1993WO1993020935A1 Activated substrate materials, their production and use
10/28/1993WO1993020852A2 Macrocyclic chelating agents, chelates and conjugates thereof
10/28/1993WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993WO1993020847A1 Vaccine adjuvant
10/28/1993WO1993020846A1 Recombinant influenza vaccines
10/28/1993WO1993020845A1 Method for treating leukotropic viral infections using an autologous leukocyte vaccine
10/28/1993WO1993020844A1 Papillomavirus e7 protein
10/28/1993WO1993020843A1 Oral treatment of helicobacter infection
10/28/1993WO1993020842A1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides
10/28/1993WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993WO1993020840A1 Induction of ctl responses
10/28/1993WO1993020831A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins
1 ... 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 ... 1823